Biological characteristics of micrometastatic carcinoma cells in bone marrow

Current Topics in Microbiology and Immunology

Volumn 213 I, Issue , 1996, Pages 163-177

  Braun, S ^a   Pantel, K ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; TUMOR MARKER;

BONE MARROW; CANCER IMMUNOLOGY; CARCINOMA; CELL PROLIFERATION; HUMAN; METASTASIS; ONCOGENE; PRIORITY JOURNAL; REVIEW;

EID: 0029976472     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-61107-0_10     Document Type: Review

References (55)

1. Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R (1993) Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Cancer Res 53: 5251-5261
2. Behrens J, Frixen U, Schipper J, Weidner M, Birchmeier W (1992) Cell adhesion in invasion and metastasis Semin Cell Biol 3: 169-178
3. Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE (1988) Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48: 1238-1243
4. Bianchi S, Paglierani M, Zampi G, Cardona G, Cataliotti L, Bonardi R, Ciatto S (1993) Prognostic significance of c-erbB-2 expression in node negative breast cancer Br J Cancer 67: 625-629
5. Fidler IJ, Hart IR (1982) Biological diversity in metastatic neoplasms origin and implications. Science 217 998-1003
6. Fidler U, Radinsky R (1990) Genetic control of cancer metastasis J Natl Cancer Inst 82 166-168
7. Freeman JW, Busch RK, Gyorkey F, Gyorkey P, Ross BE, Busch H (1988) Identification and characterization of a human proliferation-associated nucleolar antigen with a molecular weight of 120,000 expressed in early G1 phase. Cancer Res 48: 1244-1251
8. Gallee MPW, van Vroonhoven CCJ, van der Korput HAGM, van der Kwast TH, ten Kate FJW, Romijn JC, Trapman J (1986) Characterization of monoclonal antibodies raised against prostatic cell hne PC-82 Prostate 9 33-45
9. Gatter KC, Alcock C, Heryet A, Mason DY (1985) Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet 1: 1302-1305
10. Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20
11. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody kr67 J Immunol 133: 1710-1715
12. Göttlinger HG, Funke I, Johnson JP, Goket JM, Riethmuller G (1986a) The epithelial cell surface antigen 17-1 A, a target for antibody-mediated tumor therapy its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int J Cancer 38: 47-53
13. Göttlinger HG, Johnson JP, Riethmuller G (1986b) Biochemical and epitope analysis of the 17-1A membrane antigen. Hybridoma 5: 29-37
14. Hall PA, Ray A, Lemoine NR, Midley CA, Krausz T, Lane DP (1991) p53 immunostaining as a marker of malignant disease in diagnostic cytopathology Lancet 338: 531
15. Hammerling G, Maschek V, Sturmhöfel K, Momburg F (1989) Regulation and functional role of MHC expression on tumors In: Melchers F (ed) Progress in immunology. Springer, Berlin Heidelberg New York, pp 1071-1078
16. Hart IR, Goode NT, Wilson RE (1989) Molecular aspects of the metastatic cascade Biochim Biophys Acta 989: 65-84
17. Hoffman M (1992) New clue found to oncogene's role in breast cancer. Science 256 1129
18. Hogg N, Landis RC (1993) Adhesion molecules in cell interaction Curr Opin Immunol 5 383-390
19. Iggo R, Gatter K, Bartek J, Lane D, Harris AL (1990) Increased expression of mutant forms of p53 oncogene in primary lung cancer Lancet 335: 675-679
20. Johnson JP, Stade BG, Holzmann B, Schwäble W, Riethmüller G (1989) De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 86: 641-644
21. Lane DP, Benchimol S (1990) p53: oncogene or anti-oncogene? Genes Dev 4: 1-8
22. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340: 685-689
23. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis an imbalance of positive and negative regulation. Cell 64: 327-336
24. Litvinov SV, Velders MP, Bakker HAM, Fleuren GJ, Warnaar SO (1994) Ep-CAM, a human epithelial antigen is a homophilic cell-cell adhesion molecule J Cell Biol 125: 437-446
25. Lupu R, Colomer R, Kannan B, Lippman ME (1992) Characterization of a growth factor that binds exclusively to the erbB2 receptor and induces cellular responses Proc Natl Acad Sci USA 89: 2287-2291
26. Martignone S, Ménard S, Bufalino R, Cascinelli N, Pellegrini R, Tagliabue E, Andreola S, Rilke F, Cotnaghi MI (1993) Prognositc significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst 85: 398-402
27. Ménard S, Squicciarini P, Luini A, Sacchini V, Rovini D, Tagliabue E, Veronesi U, Colnaghi MI (1994) Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with tumor prognostic features. Br J Cancer 69: 1126-1129
28. Nabel GJ, Felgner PL (1993) Direct gene transfer for immunotherapy and immunization. In: Robinson C, Watson F (eds) Trends in biotechnology: gene therapy-therapeutic strategies and commercial prospects Bousfield, Cambridge, pp 211-214
29. Pallavicini MG, Cher ML, Bowers EE, Wessman M, Balouch M, Presti J, Carroll PR (1995) Chromosomal aneusomies in prostate cancer marrow micrometastases (abstract). Proc Am Assoc Cancer Res 36: 69
30. Pantel K, Schlimok G, Kutter D, Schaller G, Genz T, Wiebecke B, Backmann R, Funke I, Riethmuller G (1991) Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells Cancer Res 51: 4712-4715
31. Pantel K, Braun S, Schlimok G, Riethmüiler G (1993a) Micrometastatic tumour cells in bone marrow in colorectal cancer. Lancet 341 501
32. Pantel K, Izbicki JR, Angstwurm M, Braun S, Passlick B, Karg O, Thetter O, Riethmüller G (1993b) Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 53. 1027-1031
33. Pantel K, Schlimok G, Braun S, Kutter D, Schaller G, Funke I, Izbicki J, Riethmüller G (1993c) Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85: 1419-1424
34. Pantel K, Schmaus W, Schlimok G, Riethmüller G (1993d) p53 immunostaining of megakaryocytes is preferentially observed in patients with epithelial malignancies. Blood 82: 610a
35. Pantel K, Schlimok G, Angstwurm M, Weckermann C, Schmaus W, Gath H, Passlick B, Izbicki J, Riethmüller G (1994) Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow J Hematother 3: 165-173
36. Pantel K, Braun S, Passlick B, Schlimok G (1995) Progress in histochemistry and cytochemis try - Minimal residual epithelial cancer, diagnostic approaches and prognostic relevance. Fischer, Stuttgart
37. Pardoll DM (1993) Cancer vaccines Immunol Today 14 310-316
38. Passlick B, Izbicki JR, Simmel S, Kubuschok B, Karg O, Habekost M, Thetter O, Schwererer L, Pantel K (1994) Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas Eur J Cancer 30: 376-381
39. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y (1992) Isolation of the neu/ HER-2 stimulatory ligand, a 44 kD glycoprotein that induces differentiation of mammary tumor cells. Cell 69: 205-216
40. Pfeifer M (1993) Cancer, catenins and cuticle pattern: a complex connection. Science 262: 667
41. Price JE, Aukerman SL, Ananthaswamy N, McIntyre BW, Schackert G, Fidler IJ (1989) Metastatic potential of cloned murine melanoma cells transferred with activated c-Ha-ras Cancer Res 49. 4274-4281
42. Riesenberg R, Oberneder R, Kriegmair M, Epp M, Bitzer U, Hofstetter A, Braun S, Riethmuller G, Pantel K (1993) Immunocytochemical double staining of cytokeratin and prostate specific antigen individual prostatic tumor cells Histochemistry 99: 61-66
43. Riethmuller G, Johnson JP (1992) Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancer. Curr Opin Immunol 4. 647-655
44. Riethmuller G, Schneider-Gädicke E, Schlimok G, Schmiegel W, Raab R, Höffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, Buggisch P, Witte J The German Cancer Aid 17-1A Study Group (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes C colorectal carcinoma. Lancet 343. 1177-1183
45. Schlimok G, Funke I, Holzmann B, Göttlinger HG, Schmidt G, Häuser H, Swierkot S, Warnecke HH, Schneider B, Koprowski H, Riethmuller G (1987) Micrometastatic cancer cells in bone marrow in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci USA 84: 8672-8676
46. Schlimok G, Funke I, Pantel K, Strobel F, Lindemann F, Witte J, Riethmüller G (1991) Micrometastatic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 27: 1461-1465
47. Schlimok G, Lindemann F, Holzmann K, Witte J, Renner D, Riethmuller G (1992) Prognostic significance of disseminated tumor cells detected in bone marrow of patients with breast and colorectal cancer: a multivariate analysis Proc Am Soc Clin Oncol 11. 102
48. Schwarz MA, Owaribe K, Kartenbeck J, Franke WW (1990) Desmosomes and hemidesmosomes: Constitutive molecular components Annu Rev Cell Biol 6 461-491
49. Slamon JD, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of the HER-2/neu proto-oncogene in human breast cancer and ovarian cancer Science 244: 707-712
50. Springer TA (1990) Adhesion receptors of the immune system. Nature 346: 425-434
51. Taylor-Papadimitrou J (1994) Oncogene signalling epithelial polarity and metastatic phenotype. Proceedings of the Lancet Conference, Brugge, April 21-22, 1994. Lancet, London, p 7
52. Tiwari RK, Borgen PI, Wong GY, Cordon CC, Osborne MP (1992) HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis Anticancer Res 12 419-425
53. Tomita Y, Nishiyama T, Watanabe H, Fujiwara M, Sato S (1990) Expression of intercellular adhesion molecule-1 (ICAM-1) on renal-cell cancer: possible significance in host immune responses. Int J Cancer 46: 1001-1006
54. Varley JM, Swallow JE, Brammer WJ, Whittaker JL, Walker RA (1987) Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis Oncogene 1 423-430
55. Venter DJ, Tuzi NL, Kumar S, Gullick WJ (1987) Overexpression of the c-erb-B-2 oncoprotein in human breast carcinomas: immunhistochemical assessment correlates with gene amplification Lancet 11. 69-72